These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8107232)

  • 21. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
    Schröfelbauer B; Senger T; Manning G; Landau NR
    J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Host cell-dependent replication of HIV-1 gag MA, CA, and NC mutants are independent of the functions of Vif and Vpu.
    Shimano R; Inubushi R; Adachi A
    Int J Mol Med; 1999 Jan; 3(1):91-4. PubMed ID: 9864392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus.
    Park IW; Myrick K; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1994 Dec; 7(12):1228-36. PubMed ID: 7965633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lysine to arginine mutations in HIV-1 Vif on its expression and viral infectivity.
    Khamsri B; Fujita M; Kamada K; Piroozmand A; Yamashita T; Uchiyama T; Adachi A
    Int J Mol Med; 2006 Oct; 18(4):679-83. PubMed ID: 16964423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in the leucine zipper-like heptad repeat sequence of human immunodeficiency virus type 1 gp41 dominantly interfere with wild-type virus infectivity.
    Chen SS; Lee SF; Hao HJ; Chuang CK
    J Virol; 1998 Jun; 72(6):4765-74. PubMed ID: 9573241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1.
    Ochsenbauer C; Bosch V; Oelze I; Wieland U
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1389-95. PubMed ID: 8757978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.
    Aldrovandi GM; Zack JA
    J Virol; 1996 Mar; 70(3):1505-11. PubMed ID: 8627668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged infection of peripheral blood lymphocytes by Vif-negative HIV type 1 induces resistance to productive HIV type 1 infection through soluble factors.
    Simm M; Pekarskaya O; Potash MJ; Volsky DJ
    AIDS Res Hum Retroviruses; 2000 Jul; 16(10):943-52. PubMed ID: 10890355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.
    Nascimbeni M; Bouyac M; Rey F; Spire B; Clavel F
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1945-50. PubMed ID: 9714242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylation of Vif and its role in HIV-1 replication.
    Yang X; Goncalves J; Gabuzda D
    J Biol Chem; 1996 Apr; 271(17):10121-9. PubMed ID: 8626571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
    Zhang H; Pomerantz RJ; Dornadula G; Sun Y
    J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Vif accessory protein alters the cell cycle of human immunodeficiency virus type 1 infected cells.
    Wang J; Shackelford JM; Casella CR; Shivers DK; Rapaport EL; Liu B; Yu XF; Finkel TH
    Virology; 2007 Mar; 359(2):243-52. PubMed ID: 17056089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the cell-dependent replication potentials of human immunodeficiency virus type 1 vif mutants.
    Fujita M; Sakurai A; Doi N; Miyaura M; Yoshida A; Sakai K; Adachi A
    Microbes Infect; 2001 Nov; 3(13):1093-9. PubMed ID: 11709289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Partial rescue of the Vif-negative phenotype of mutant human immunodeficiency virus type 1 strains from nonpermissive cells by intravirion reverse transcription.
    Dornadula G; Yang S; Pomerantz RJ; Zhang H
    J Virol; 2000 Mar; 74(6):2594-602. PubMed ID: 10684273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation.
    Farrow MA; Somasundaran M; Zhang C; Gabuzda D; Sullivan JL; Greenough TC
    AIDS Res Hum Retroviruses; 2005 Jun; 21(6):565-74. PubMed ID: 15989462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
    Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
    J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child.
    Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA
    J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
    Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells.
    von Schwedler U; Song J; Aiken C; Trono D
    J Virol; 1993 Aug; 67(8):4945-55. PubMed ID: 8331734
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Persistent infection of MT-4 cells by human immunodeficiency virus type 1 becomes increasingly likely with in vitro serial passage of wild-type but not nef mutant virus.
    Nishino Y; Nakaya T; Fujinaga K; Kishi M; Azuma I; Ikuta K
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2241-51. PubMed ID: 7521392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.